| Similar Articles |
|---|
 |
Bio-IT World
May 7, 2002
Davies & Levitt |
Bridge Over Troubled Waterford Project For a project that links some of the best institutions and minds in AIDS research in order to produce an effective vaccine that could save millions of lives, funding should be a nonissue. Unfortunately, that is not the case -- and the bio-IT community has to find a way to remedy this issue.   |
Wired
January 2003
Richard Martin |
Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine. |
| AskMen.com |
Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. |
Fast Company
August 8, 2011
Kate Rockwood |
AIDS Vaccine Conference Despite billions in annual research dollars, the quest for an AIDS vaccine remains elusive. |
Chemistry World
February 9, 2007
Victoria Gill |
Africa's First Large-Scale HIV Vaccine Trial The first large-scale clinical trial of an HIV vaccine will involve around 3000 participants in five selected sites in South Africa. It will compare the effectiveness of the vaccine at reducing HIV infection compared to a placebo. |
Pharmaceutical Executive
June 1, 2005
Seth Berkley |
Backpage: Partnering for Vaccine Victories Public-private partnerships can help engage industry in AIDS vaccine research. Pharma and biotechnology companies should respond with the expertise that only they can offer. |
Salon.com
June 9, 2000
Arthur Allen |
Heart of darkness A team of Los Alamos researchers traces AIDS back to the 1930s, blowing a hole in the most recent theory about its origin. |
IDB America
September 2001
Charo Quesada |
The cost of silence The executive director of UNAIDS urges Latin America and the Caribbean to break the silence surrounding AIDS if they wish to avert greater tragedy... |
The Motley Fool
September 24, 2009
Brian Orelli |
Drugmakers' HIV Treatments Live On Companies that make HIV drugs could lose billions of dollars in revenue if an effective vaccine is developed. All drug-company investors need to keep an eye on up-and-coming drugs from competitors that could take market share. |
Salon.com
July 28, 2000
Kate Scanell |
Contributing to genocide By giving HIV deniers a global platform, South African President Mbeki has put countless lives at risk. |
Finance & Development
March 1, 2002
Robert Hecht |
Making AIDS Part of the Global Development Agenda AIDS is not just a health issue but a development problem that must be addressed at the global level. As countries increasingly recognize the need to incorporate strategies for tackling AIDS in their national policy frameworks, they are looking at new national poverty reduction plans... |
Salon.com
August 21, 2001
David Horowitz |
The AIDS obstructionists As the AIDS epidemic spins out of control, special interest groups are preventing one of the only things that can work -- mandatory testing... |
